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The reactions of serum cholinesterase with organic cations, 
such as decamethonium and atropine, as well as with inorganic 
cations, such as Sc3+, Eu3+, and Yb3+, have been studied. Graphical 
analysis of the inhibition of serum cholinesterase by decamethonium 
and lanthanide ions revealed a linear mixed inhibition. Atropine 
inhibited competitively serum cholinesterase with butyrylcholine or 
acetylcholine as a substrate, whereas with benzoylcholine as · a 
substrate atropine increased the enzyme activity. The acceleration 
of benzoylcholine hydrolysis by the simultaneous action of atropine 
and EuCla was more pronounced than with atropine alone. The 
concentrati0tn of EuCI3 which practically did not affect the 
enzyme activity, decreased the inhibition of serum cholinesterase 
by o-tubocurarine. It was suggested that the mixed type of 
inhibition of serum cholinesterase by decamethonium and the 
lanthanide ions, as well as the effect of the combined action of 
organic cations and lanthanides on the enzyme activity, might 
reflect the allosteric properties of serum cholinesterase. 
INTRODUCTION 
There are many similarities and differences between serum cholinesterase 
(serum ChE) and acetylcholinesterase (AChE). Since serum ChE is in its native 
form soluble, it is less affected by various preparation procedures than 
membrane bound AChE. The catalytic sites of the two enzymes are considered 
to be similar, consisting of one anionic and one esteratic subsite, the difference 
being in the hydrophobic areas1•2. Kinetically the two enzymes differ in many 
respects, especially in the steric requirements for substrates and inhibitors3•4 . 
The reactions of serum ChE with acylating agents were more .intensively 
studied than those with noncovalently acting agents5. However, re::lctions of 
serum ChE with organic cations, such as mono- and bis-quaternary am-
monium ions, proved the existence of an anionic subsite in the catalytic site of 
serum ChE6• The organic cation n-tubocurarine (TC), which is a cholinoreceptor 
blocking agent, was an important tool in the study of AChE reactions as a 
model for cholinoreceptor reactions. Recently it has been shown that the 
inhibition of serum ChE by TC is of the mixed type; this was interpreted as 
pointing to an allosteric binding of TC to the enzyme protein9 • One aim of 
the present work was to investigate the influence of organic cations deca-
methonium (DM) and atropine (Atr) on serum ChE activity. These two com-
pounds interfere with the cholinoreceptor and the AChE reactions7•8• 
Bivalent inorganic cations influence the activity of serum ChE, but the 
mechanism of this effect is not clear. Van der Meer10 obtained 10 to 250/o 
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activation of serum ChE by Ca2+ with acetylcholine (ACh) as a substrate, while 
with the uncharged substrate butylacetate, the activation was of the order of 
1000/o. Hofstee11 found that bivalent metal ions greatly increase the rate of 
hydrolysis of the ·phenothiazine derivatives catalyzed by serum ChE and inter-
preted his finding in the sense that in addition to the catalytic site an auxiliary 
group was present on the enzyme molecule. Recently, lanthanide ions were 
suggested as isomorphus substitutes for Ca2+ binding sites in proteins12• Thus 
the second aim of this work was to find whether and how scandium, europium, 
and ytterbium ions interact with serum ChE and how they influence the inter-
actions of serum ChE with some organic cations. 
MATERIALS AND METHODS 
The two serum ChE preparations were: 1) horse serum, diluted 30-times in the 
assay sample; and 2) a filter cake obtaimed from the fifth stage on the serum ChE 
purification according to Strelitz (250 enzyme units per mg of protein); the con-
centration in the assay sample was 10 µg per ml. Substrates: butyrylcholine iodide 
(BuCh) in concentrations from 0.5 mM to 20 mM, butyrylthiocholine iodide (ButhCh) 
from 0.02 mM to 20 mM, ACh iodide from 1 mM to 20 mM, and benzoylcholine 
chloride (BzCh) from 1 mM to 10 mM. Organic salts: DM iodide from 0.05 mM to 5 
mM, Atr (as sulfate) from 0.05 mM to 10 mM (with regard to Atr), TC chloride in 
concentrations 0.1 mM and 1 mM, and 0.01 ~LM eserine (as sulfate; concentration 
with regard to eserine). All substrates, as well as organic and inorganic salts, were 
obtained from Koch-Light. Molar solutions of lanthanide chlorides were prepared 
in 10 mM HCl and diluted and neutralized by 10 mM NaOH before use. 
The experiment with exhausting dialysis was performed at 4 °c against phy-
siological solution buffered with veronal-Na to pH=7.0. When the experiment 
required 24 h incubation time the enzyme-inhibitor solution and the normal sample 
were buffered with veronal-Na to pH= 7.0 and kept at 4 °c. 
The enzyme activity was measured with a Radiometer automatic titrator (Type 
TTTlc titrator, ABUlb automatic buret, TTA3 titration assembly, and SBR2c re-
corder) . To the enzyme preparation (in saline solution without buffer adjusted to 
and kept at pH=7.0 with NaOH solution) one of the organic or inorganic salts, or 
a mixture of the two and the substrate, were added. In the experiments with the 
purified enzyme preparation, a gelatine solution was added to the saline solution 
in order to obtain a final gelatine concentration of 0.02°/o. In one series of the 
assays with a lanthanide and an organic salt the former was added before the latter, 
whereas in another series the order was reversed. The · measurements were carried 
out at an ionic strength of 0.17 M and 25 °C, in at least three parallel runs. The 
10 mM solution of NaOH was prepared every day in a nitrogen atmosphere and 
bubbled through with nitrogen duriing measurements. A flow of nitrogen was also 
maintained over the surface of the reaction solution. The value of the non-en-
zymatic hydrolysis rate of the substrate was measured and subtracted from the 
value of the corresponding enzyme hydrolysis rate. 
The dependence of the initial hydrolysis rates on the concentration of organic 
or lanthanide salts at different substrate concentrations was graphically analyzed 
according to Dixon and Cornish-Bowden13• In some experiments the inhibition was 
analyzed by the Lineweaver-Burk plot. 
RESULTS AND DISCUSSION 
The graphical analysis according to Cornish-Bowden13 of the inhibition 
of serum ChE by DM with BuCh as a substrate revealed that the inhibition 
was of the mixed type (Fig. l); the constant for the noncompetitive component 
of inhibition (K{) was 0.90 mM, whereas the constant for the competitive 
inhibition determined by the Dixon p lot was 75 µM. Practically the same 
results were obtained with diluted horse serum and with the partially purified 
enzyme preparation. Linear mixed inhibition occurs if an inhibitor and a 
homogeneous enzyme protein form the EIS complex or if an inhibitor and an 
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Fig. 1. Inhibition of horse serum cholinesterase by decamethonium; substrate butyry lcholine 
(Cornish-Bowden plot); titrimetric data at pH = 7.0 and 25 •c. 
acylated enzyme form a binary complex. These two types of complexes point 
to an important difference in the nature of the interaction between an inhi-
bitor and an enzyme protein. In the case of the complex EIS, the allosteric 
properties of an enzyme protein are implied, whereas the binding of an 
inhibitor to an acylated enzyme can induce a localized conformational change 
only in the active site; this phenomenon might manifest in the form of mixed 
inhibition. The formation of a complex inhibitor-acylated enzyme has been 
suggested for the interaction of some organic cations with AChE14• If the 
inhibition of serum ChE by DM is studied, the ·possibility that acylated serum 
ChE might form a complex with the inhibitor can not be exduded. But, in 
the view of the fact that the tetraethylammonium ion only slightly activates 
serum ChE at lower pH values15, and that the acceleration by tetraethylam-
monium ion of the inhibition of serum ChE by methanesulfonyl fluoride is 
around ten times lower than in the case of AChE16, it can be assumed 
that conformational changes induced by the binding ·Of an inhibitor to the 
acylated serum affect the activity of the esteratic subsite of serum ChE in 
a lesser . degree than in the case of AChE. 
Further, the possibility that serum ChE is not a single enzyme but a 
mixture of isoenzymes should also be considered. The existence of isoenzymes 
of serum ChE was demonstrated by several authors17- 19 . Recently, four isoen-
zymes of serum ChE with different values of K m were obtained by means of 
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polyacrylamide gel electrophoresis. The value of Km for ButhCh of the pre-
dominant isoenzyme was found20 to be (2.46 ± 0.73) mM. The value of Km for 
ButhCh of both our serum ChE preparations (diluted horse serum and partially 
purified serum ChE) was around 0.27 mM. These data permit the conclusion 
that under our experimental conditions serum ChE was practically homo-
geneous. 
On the basis of formal kinetic data nothing definite can be said about the 
nature of the binding of an inhibitor to an enzyme protein. We suggest only 
that the mixed inhibition of serum ChE by DM is a manifestation of the 
existence of a ternary EIS complex rather than of the binary complex of DM 
with the acylated enzyme. 
It is generally considered that the interaction of DM with AChE is isosteric 
and allosteric7,s,21 ,22 . Thus, it seems that in this respect the reaction of DM 
with serum ChE resembles the reaction of DM with AChE. An analogous 
similarity was found for the interaction of serum ChE with TC and that of 
AChE w.ith TC9. 
Atropine is the oldest known and the most important antagonist of the 
ACh action at the muscarinic cholinoreceptor23. The fact that · after 24 hours 
the inhibition of serum ChE by Atr was no weaker than after a few minutes, 
permits the assumption that Atr, in spite of its carbonyl group, is not a 
substrate for serum ChE. From the experiments with Atr and eser,ine acting 
simultaneously on serum ChE (Table I) it might be assumed that Atr does 
TABLE I. 
The influence of atropine (Atr) and eserine (E) on the rate (V) of serum cholinesterase -
-catalyzed hydr-0lysis of benzoylcholine (BzCh). Titrimetric data at ;pH= 7.0 and 25 °c. 
Agent 
BzCh 
BzCh + Atr 
BzCh + E 


























not bind to the esteratic subsite of serum ChE. The Dixon plot (BuCh as 
substrate) and the Lineweaver- Burk (ACh as substrate) revealed that the 
inhibition of serum ChE by Atr was competitive (Figs. 2 and 3), whereas 
with BzCh as a substrate Atr activated serum ChE. The acceleration of serum 
ChE-catalyzed hydrolysis of BzCh by Atr depends on the concentration ratio 
between Atr and BzCh24 and on pH; at pH = 7.0 the highest acceleration was 
about 1200/o, whereas at pH = 5.5 it was about 500!0/o (Fig. 4). Acceleration 
effects of Atr on benzoylcholine hydrolysis might be due to a conformational 
change induced by the binding of Atr to the anionic subsite of the benzoylated 
serum ChE. However, Atr does not practically accelerate the inhi1bition of 
serum ChE by methanesulfonyl fluoride (Pavlic, personal communication). 
Competitive inhibition might point to isosteric binding only if the structure 
of the inhibitor and that of the substrate closely resemble each other. A 














Fig. 2. Inhibition of horse serum cholinesterase by atropine; substrate butyrylcholine; titri-
metric data at pH = 7.0 and 25 •c. 
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Fig. 4. The influence of atropine on the activity of serum cholinesterase with benzoylcholine as 
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Fig. 5. Inhibition of serum cholinesterase by ScCb ; substrate butyrylcholine (Cornish -Bowde n 
plot); titrimetric data at pH = 7 .o and 25 •c. 
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structural relationship between Atr and ACh is not obvious at first sight. 
Then, in such a case competitive inhibition might be due to a steric hindrance. 
Some years ago allosteric binding of Atr to AChE was shown by means of 
n. m. r. spectroscopy even though the inhibition of AChE by Atr with ACh at 
suboptimal concentrations is competitive26,27• 
The hydrolysis of lanthanide ions limits the pH range over which mea-
surements can be done without observable precipitaition of the metal ions. 
Thus 7.0 was the highest pH value at which the inhibition of serum ChE by 
lanthanide ions was studied. The inhibition of serum ChE (ACh or BuCh as 
substrates) by lanthanide ions was of the mixed type (Figs. 5 and 6). ScC13 
inhibited serum ChE most strongly; 3 mM ScCl3 completely inhibited serum 
ChE, but 'practically all enzyme activity was recovered by exhaustive dialysis. 
The inhibition of serum ChE by YbC13 was weaker, whereas EuCl3 in con-
centrations up to 1 mM did practically not inhibit the enzyme activity. The 
inhibition of serum ChE by EuCl3 at higher concentrations was likewise of 
the mixed type. The hydrogen ion interfered with the inhibition of serum 
ChE by ScCl3 noncompetitively (Fig. 7). It seems that Sc ions can block the 
mM 
CAChJ 
2rnM YbC L3 
1.0 
Fig. 6. Inhibition of serum cholinesterase by YbCla; substra te acetylcholine; titrimetric da ta 
at pH = 7.0 and 25 •c. 
sites in the enzyme protein for which hydrogen and substrate ions compete; 
as a consequence of this competition the pH dependence of the enzyme activity 
in the presence of lanthanide ions is similar to the pH dependence in the case 
of an uncharged substrate28• 
Comparing the effect of lanthanide ions and that of Ca2+ on serum ChE 
activity one can see that Ca2+ in concentrations up to 50 mM increases Km as 
well as V m, thus acting as an activator29 • However the activating effect of 
a metal ion defines neither its structural association with an enzyme nor its 
physiological function30• The inhibitory effect of a metal ion might be more 
helpful for the study of a metal ion with an enzyme protein. The inhibitory 
effect of ScCl" is comparable to that of organic cations, but EuCl3 is a very 






























F'i g . 7. The influence of pH on the inhibition of serum cholinesterase by 0.5 mM ScCb; substrate 
acetylcholine; titrimetric data at pH = 6.5 and 7.0, 25 oc. 
activity, EuCl3 decreases the inhibition of serum ChE by TC {Table II) and by 
DM (Table III). EuCl3 accelerated the hydrolysis of BzCh, but this accelaration 
vvas less pronounced than with Atr. However, when Atr and EuCl0 simul-
TABLE II. 
The effect of D-tubocurarine (TC) and EuC13 on the activity of serum cholinesterase. 
Titrimetric data with 10 mM butyrylchoiine, pH= 7.0, 25 °c. 
Inhibitor 
0.1 mM TC 
mM TC 
mM EuCla 
0.1 mM TC + 1 mM EuCJ3 
1 mM TC + 1 mM EuC13 
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TABLE III. 
The effect of decamethonium (DM) and lanthanide chlorides on the activity of 




1 mM ScC13 
1 mM EuC13 
1 mM YbCls 
1 mM DM + 1 mM ScC13 
1 mM DM + 1 mM EuC13 










The effect of atropine (Atr) and lanthanide chlorides on the activity of serum cho-
linesterase. Titrimetric data at pH= 7.0 and 25 °c. Substrate: 10 mM benzoylcholine. 
Activator or inhibitor Activity (O/o) 
1 mM Atr 165 
mM ScCls 25 
1 mM EuC13 138 
1 mM YbC13 75 
1 mM Atr + 1 mM ScCla 39 
1 mM Atr + 1 mM EuCla 197 
1 mM Atr + 1 mM YbC13 147 
taneously acted on serum ChE the acceleration of BzCh hydrolysis was about 
200/o greater than in the oase of Atr alone (Table IV). The same result was 
obtained regardless of the order of addition of the activators. 
Regarding the magnetic properties of lanthanide ions (all hut Sc, Sm, and 
La are paramagnetic} and their effects on serum ChE reactions, it might be 
assumed that lanthanide ions can be good spectroscopic probes of metal ion 
binding sites in serum ChE. 
The mixed type of inhibition of serum cholinesterase by decamethonium 
and lanthanide ions as well as the effect of the combined action of organic 
cations and lanthanides on the enzyme activity permits the assumption that 
these reactions reflect allosteric properties of serum ChE. If this assumption is 
correct then the question arises of the physiological or pharmacological signi-
ficance of this allosterism. The possible role of the allosterism of serum ChE 
might be that the binding properties and binding capacity of serum ChE are 
involved in the control of the concentration of various physiologically or 
pharmacologically active cations, to which membrane bound cholinesterases 
are more sensitive than serum ChE. 
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DISCUSSION 
M. E. Eldefrawi: 
Europium and terbium solutions are highly fluorescent, a nd we find that the 
ACh-receptor protein binds these ions, and when bound their fluorescence intensity 
increases several fold. Have you observed anything similar with butyrylcholin-
esterase and these ions? 
Lj. Kamaric: 
I have not measured the fluorescence intensity. I only studied the effect of 
scandium, europium and ytterbium ions on the overall reaction of horse serum 
cholinesterase. 
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TABLE III. 
The effect of decamethonium (DM) and lanthanide chlorides on the activity of 
serum choiinesterase; titrimetric data at pH = 7.0 and 25 °c. Substrate: 10 mM 
butyrylchoiine. 
Inhibitor 
1 mM DM 
1 mM ScC13 
1 mM EuC13 
l mM YbCl3 
1 mM DM + 1 mM ScC13 
1 mM DM + 1 mM EuCI3 . 










The effect of atropine (Atr) and lanthanide chlorides on the activity of serum cho-
linesterase. Titrimetric data at pH = 7.0 and 25 °c. Substrate: 10 mM benzoylcholine. 
Activator or inhibitor Activity (O/o) 
1 mM Atr 165 
1 mM ScCla 25 
1 mM EuCl3 138 
1 mM YbCl3 75 
1 mM Atr + 1 mM ScCl3 39 
1 mM Atr + 1 mM EuCl3 197 
1 mM Atr + l mM YbCl3 147 
taneously acted on serum ChE the acceleration of BzCh hydrolysis was about 
200/o greater than in the case of Atr alone (Table IV). The same result was 
obtained regardless of the order of addition of the activators. 
Regarding the magnetic properties of lanthanide ions (all but Sc, Sm, and 
La are paramagnetic) and their effects on serum ChE reactions, it might be 
assumed that lanthanide ions can be good spectroscopic probes of metal ion 
binding sites in serum ChE. 
The mixed type of inhibition of serum cholinesterase by decamethonium 
and lanthanide ions as well as the effect of the combined action of organic 
cations and lanthanides on the enzyme activity permits the assumption that 
these reactions reflect allosteric properties of serum ChE. If this assumption is 
correct then the question arises of the physiological or pharmacological signi-
ficance of this allosterism. The possible role of the allosterism of serum ChE 
might be that the binding properties and binding capacity of serum ChE are 
involved in the control of the concentration of various physiologically or 
pharmacologically active cations, to which membrane bound cholinesterases 
are more sensitive than serum ChE. 
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DISCUSSION 
M. E. Eldefrawi: 
Europium and terbium solutions are highly fluorescent, and we find that the 
ACh- receptor protein binds these ions, and when bound their fluorescence intensity 
increases several fold. Have you observed anything simila r with butyrylcholin-
esterase and these ions? 
Lj. KamariC: 
I have not measured the fluorescence intensity. I only studied the effect of 
scandium, europium and ytterbium ions on the overall reaction of home serum 
cholinesterase. 
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E. Heilbronn: 
Do you happen to know if any atr.opinesterase activity is present in your serum 
preparations? 
Lj. Kamaric: 
Atropine was not hydrolysed either by diluted horse serum or by purified 
serum cholinesterase preparations. 
IZVLECEK 
AlosteriCne reakcije serumske holinesteraze 
Lj. Kamaric 
Pri proucevanju reakcij serumske holinesteraze z organskimi kationi, kot sta 
dekametonij in atropin, ter anorganskimi, kot so ioni Sc, Eu in Yb, se je pokazalo, 
da je inhibicija serumske holinesteraze z dekametonijem in z lantanidi linearne 
mesane vrste. Atropin je pri butirilholinu ali acetilholinu kot substratu inhibiral 
serumsko holinesterazo kompetitivno, medtem ko je .pri bencoilholinu kot substratu 
zveeal encimsko aktivnost; Atropin in EuCl3 sta skupaj bolj kot sam atropin pospe-
Sila hidrolizo bencoilholina. V koncentraciji, ki prakticno ne vpliva na encimsko 
aktivnost, je EuCl3 zmanjsal inhibicijo serumske holinesteraze z D-tUJbokurarinom. 
Domneva se, da bi mesana inhibicija serumske holinesteraze z dekametonijem in 
lantanidi kot tudi ucinek skupnega delovanja organskih kationov in lantanidov na 
encimsko aktivnost mogla odsevati alostericne lastnosti serumske holinesteraze. 
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